Centene Corporation
Centene Corporation Reaffirms 2024 Guidance and Provides 2025 Financial Outlook
Summary
On December 12, 2024, Centene Corporation, a leading healthcare enterprise, announced its financial guidance for 2025, projecting adjusted diluted earnings per share (EPS) greater than $7.25, alongside reaffirming its 2024 guidance. The Company hosted a virtual investor day to discuss these projections. The guidance includes total revenues between $166.5 billion and $169.5 billion for 2025 and reaffirms its 2024 premium and service revenues in the range of $143.5 billion to $144.5 billion. Centene's 2024 full-year earnings are scheduled to be reported on February 4, 2025.
Profitelligence Alerts
Get alerts for CNC
Be first to know when Centene Corporation files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Centene Corporation
Centene Corporation is a diversified healthcare enterprise providing a comprehensive range of managed care services to government-sponsored healthcare programs. Specializing in serving uninsured and underinsured populations, Centene offers health plans, benefits management, and other related services. It operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Medicaid, Medicare Advantage, and the Health Insurance Marketplace, impacting millions of lives across the United States. Meanwhile, the Specialty Services segment enhances healthcare quality and affordability through offerings such as pharmacy solutions, behavioral health, and optometry services. Founded in 1984 and headquartered in St. Louis, Missouri, Centene plays a significant role in the healthcare sector by addressing accessibility and cost challenges, thereby shaping market trends and influencing policy developments. As a major participant in the managed care industry, Centene is crucial for promoting coordinated care and improving health outcomes for vulnerable populations.
Official SEC Documents
Advertisement